AVISE PG is the first and only testing service to measure methotrexate (MTX) polyglutamates, the active metabolites of MTX. Avise PG can help you determine whether partial or nonresponders to MTX may benefit from continued dose escalation or may need a change in therapy. Read more...

Avise Personalized Medicine Services leverage the latest laboratory technologies to facilitate improved diagnostic and therapeutic
decision making

AVISE MCV is a sensitive and specific test service that improves upon traditional means of diagnosing rheumatoid arthritis (RA). Targeting autoantibodies that are naturally occurring within the inflamed synovium of patients with RA, Avise MCV offers a high level of diagnostic accuracy with the added benefit of identifying patients who are likely to have more severe disease progression. Read more...